WallStSmart

Cango Inc (CANG)vsNomura Holdings Inc ADR (NMR)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Nomura Holdings Inc ADR generates 314938% more annual revenue ($2.17T vs $688.08M). NMR leads profitability with a 16.7% profit margin vs -90.4%. NMR earns a higher WallStSmart Score of 70/100 (B-).

CANG

Hold

49

out of 100

Grade: D+

Growth: 10.0Profit: 2.0Value: 5.0Quality: 5.0
Piotroski: 4/9Altman Z: -0.36

NMR

Strong Buy

70

out of 100

Grade: B-

Growth: 7.3Profit: 6.5Value: 7.7Quality: 3.5
Piotroski: 4/9Altman Z: 0.53

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CANG4 strengths · Avg: 9.8/10
Price/BookValuation
0.3x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
87.9%10/10

Revenue surging 87.9% year-over-year

EPS GrowthGrowth
137.3%10/10

Earnings expanding 137.3% YoY

Debt/EquityHealth
0.169/10

Conservative balance sheet, low leverage

NMR4 strengths · Avg: 9.0/10
P/E RatioValuation
11.8x10/10

Attractively priced relative to earnings

Price/BookValuation
1.0x10/10

Reasonable price relative to book value

PEG RatioValuation
0.828/10

Growing faster than its price suggests

Revenue GrowthGrowth
27.5%8/10

Revenue surging 27.5% year-over-year

Areas to Watch

CANG4 concerns · Avg: 2.3/10
Market CapQuality
$171.06M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-210.2%2/10

ROE of -210.2% — below average capital efficiency

Free Cash FlowQuality
$-1.57B2/10

Negative free cash flow — burning cash

Altman Z-ScoreHealth
-0.362/10

Distress zone — elevated risk

NMR4 concerns · Avg: 2.3/10
EPS GrowthGrowth
4.5%4/10

4.5% earnings growth

Free Cash FlowQuality
$-1.20T2/10

Negative free cash flow — burning cash

Altman Z-ScoreHealth
0.532/10

Distress zone — elevated risk

Debt/EquityHealth
4.671/10

Elevated debt levels

Comparative Analysis Report

WallStSmart Research

Bull Case : CANG

The strongest argument for CANG centers on Price/Book, Revenue Growth, EPS Growth. Revenue growth of 87.9% demonstrates continued momentum.

Bull Case : NMR

The strongest argument for NMR centers on P/E Ratio, Price/Book, PEG Ratio. Profitability is solid with margins at 16.7% and operating margin at 18.7%. Revenue growth of 27.5% demonstrates continued momentum.

Bear Case : CANG

The primary concerns for CANG are Market Cap, Return on Equity, Free Cash Flow.

Bear Case : NMR

The primary concerns for NMR are EPS Growth, Free Cash Flow, Altman Z-Score. Debt-to-equity of 4.67 is elevated, increasing financial risk.

Key Dynamics to Monitor

CANG profiles as a hypergrowth stock while NMR is a growth play — different risk/reward profiles.

NMR carries more volatility with a beta of 0.61 — expect wider price swings.

CANG is growing revenue faster at 87.9% — sustainability is the question.

CANG generates stronger free cash flow (-1.6B), providing more financial flexibility.

Bottom Line

NMR scores higher overall (70/100 vs 49/100), backed by strong 16.7% margins and 27.5% revenue growth. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Cango Inc

FINANCIAL SERVICES · CAPITAL MARKETS · China

Cango Inc. operates an automotive transaction services platform that connects dealers, original equipment manufacturers, financial institutions, car buyers, and other industry players in the People's Republic of China. The company is headquartered in Shanghai, the People's Republic of China.

Nomura Holdings Inc ADR

FINANCIAL SERVICES · CAPITAL MARKETS · USA

Nomura Holdings, Inc. provides various financial services to individuals, corporations, financial institutions, governments, and government agencies worldwide. The company is headquartered in Tokyo, Japan.

Want to dig deeper into these stocks?